Cannabics Pharmaceuticals P/E (Kainos ir pajamų santykis) 2024

Ką veikia Cannabics Pharmaceuticals?

Cannabics Pharmaceuticals Inc. is a global company that specializes in the development of personalized therapies using medical cannabis. The company was founded in Israel in 2010 and is headquartered in Tel Aviv. Since then, the company has become a leading player in the medical cannabis industry and has expanded to the United States and Europe. The company's history began with a groundbreaking discovery by the founder's team, who found a method for isolating cannabinoids from cannabis and discovered that cannabinoids have the potential to kill tumor cells. This discovery became the company's passion and they began to focus on the production of personalized therapies using medical cannabis. Cannabics' business model consists of three main divisions: research and development, manufacturing, and commercial distribution of medical cannabis. The company is able to develop personalized therapies that take into account the specific needs of each patient by following a comprehensive approach that considers the specific needs of each patient. Cannabics' research and development department focuses on the development of new personalized therapies and medical devices that include cannabis components. This includes clinical studies to demonstrate the efficacy and safety of cannabis-based medications. The company also works closely with renowned research and development institutions to leverage the latest research and technology. The manufacturing of medical cannabis is another important division of Cannabics. The company operates as a supplier, producing high-quality, personalized cannabis oil specifically tailored to meet the patient's needs. Cannabics works with various strains and cannabis extracts to ensure that each formulation contributes to symptom relief and is safe and effective. Commercial distribution is the third pillar of Cannabics' business model. The company aims to provide its personalized therapies through pharmacies and direct distribution channels to ensure that they reach patients worldwide. Cannabics offers a variety of products, including personalized doses of medical cannabis oil, specific terpene profiles, capsules, extracts, and orally administered medications. The company also offers cannabis tests that are specifically tailored for profiling cancer cells and enabling specific personalization. In recent years, the company has focused on the development of personalized therapies for the treatment of cancer. One of its notable developments is the "Cannabics SR" platform, which provides personalized treatment options for each individual patient based on their cancer genetics. The platform consists of a diagnostic tool to determine the patient's individual cancer and tumor profile. Based on these analyses, the company then formulates a tailored medical treatment using different cannabinoids. Overall, Cannabics Pharmaceuticals Inc. has become a leading company in the medical cannabis industry. The company places a strong emphasis on research and development to develop personalized therapies for the treatment of cancer and other medical conditions and to distribute them worldwide. Cannabics Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.